Speaker illustration

Ms Elisabeth Smits

Pharmo Institute, Utrecht (Netherlands (The))

Bleeding risk and healthcare resource utilisation in elderly patients treated with edoxaban or vitamin K antagonists for atrial fibrillation in Italy

Event: EHRA 2021

Topic: Treatment

Session: Optimal therapy of atrial fibrillation

Thumbnail

Stroke associated with non-adherence and non-persistence with direct oral anticoagulants in Germany

Event: EHRA 2021

Topic: Treatment

Session: ePoster session

Thumbnail